Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May:110:260-275.
doi: 10.1016/j.bbi.2023.03.002. Epub 2023 Mar 9.

Reduction in GABAB on glia induce Alzheimer's disease related changes

Affiliations

Reduction in GABAB on glia induce Alzheimer's disease related changes

Amanda M Leisgang Osse et al. Brain Behav Immun. 2023 May.

Abstract

Alzheimer's Disease (AD) is a neurodegenerative disorder characterized by beta-amyloid plaques (Aβ), neurofibrillary tangles (NFT), and neuroinflammation. Data have demonstrated that neuroinflammation contributes to Aβ and NFT onset and progression, indicating inflammation and glial signaling is vital to understanding AD. A previous investigation demonstrated a significant decrease of the GABAB receptor (GABABR) in APP/PS1 mice (Salazar et al., 2021). To determine if changes in GABABR restricted to glia serve a role in AD, we developed a mouse model with a reduction of GABABR restricted to macrophages, GAB/CX3ert. This model exhibits changes in gene expression and electrophysiological alterations similar to amyloid mouse models of AD. Crossing the GAB/CX3ert mouse with APP/PS1 resulted in significant increases in Aβ pathology. Our data demonstrates that decreased GABABR on macrophages leads to several changes observed in AD mouse models, as well as exacerbation of AD pathology when crossed with existing models. These data suggest a novel mechanism in AD pathogenesis.

Keywords: Alzheimer’s Disease; Amyloid; Electrophysiology; Flow cytometry; GABABR; Glia; Mouse models; NanoString.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Figure 1.
Figure 1.. Flow cytometric verification of GABAB1 receptor subunit knockdown and expression of YFP in males.
(A) Representation of gating strategy used for data analysis. (B) Percent of parent population (CD11b+/CD45+) that was positive for GABAB1, GABAB2, and total CD11b+/CD45+ cells. Significant differences in GABAB1 and GABAB2 receptor subunits between controls and GAB/CX3ert mice indicate recombination resulted in knockdown of the GABAB receptor. (C) YFP is significantly expressed in the GAB/CX3ert mice indicating genetic recombination. Data analysis through IBM SPSS Statistics v24. All data are shown as mean (±SEM); *p<.05.
Figure 2.
Figure 2.. Flow cytometric evaluation of GABAB1 receptor subunit knockdown and expression of YFP in females.
(A) Representation of gating strategy used for data analysis. (B) Percent of parent population (CD11b+/CD45+) that was positive for GABAB1, GABAB2, and total CD11b+/CD45+ cells. No significant differences were observed in GABAB1 and GABAB2 receptor subunits between controls and GAB/CX3ert mice. (C) YFP is significantly expressed in the GAB/CX3ert mice indicating some genetic recombination in samples. Data analysis through IBM SPSS Statistics v24. All data are shown as mean (±SEM); *p<.05.
Figure 3.
Figure 3.. GABA/CX3ert and APP/PS1 mice have fewer sharp-wave ripples and hippocampal-prefrontal hypersynchrony.
(A) Example raw and filtered (150 – 250 (Hz)) traces and spectrograms from C57Bl/6J (top), GABACX3rt (middle), and APP/PS1 (bottom) from raw and filtered hippocampal wires. APP/PS1 and GABA/CX3rt exhibit fewer sharp-wave ripples (SWRs) than C57Bl/6Jmice. (B - G) Comparison of SWR activity of C57Bl/6J, GABACX3rt, and APP/PS1 mice. (B) Frequency of SWR events; (C) Max frequency of hippocampal activity during SWR; (D) max power spectral density in the hippocampus during SWR; (E) duration of SWRs; (F) the maximum amplitude of hippocampal wires during SWR; (G) max power spectral density in the prefrontal cortex during SWR. Average values are shown for each of the five mice group mean + S.E.M; * p < 0.05. (H - L) Hippocampal - prefrontal Coherence. (H) Average hippocampal - prefrontal coherogram across groups. Note the color bar represents the minimum and maximum coherence values. (I) Delta coherence between the mPFC and HC is higher in APP/PS1 mice than C57Bl/6J and GABA/CX3rt mice. (J) Theta coherence between the mPFC and HC is not significantly different across groups. (K) Slow gamma coherence between the mPFC and HC is significantly higher in APP/PS1 and GABA/CX3rt mice compared to C57Bl/6J. (L) Fast gamma coherence between the mPFC and HC is not significantly different across groups. Average values are shown for each of the five mice group mean + S.E.M; * p < 0.05.
Figure 4:
Figure 4:. Comparison of gene expression changes of the 770 transcripts on the NanoString panel between pairs of mouse models.
(A) GAB/CX3ert mice showed strong positive correlation (Pearson correlation coefficient = 0.64, p < 2.2 × 10−16) with APP/PS1 mice. (B) GAB/CX3ert x APP/PS1 mice showed strong positive correlation (Pearson correlation coefficient = 0.61, p < 2.2 × 10−16) with APP/PS1 mice. (C) GAB/CX3ert mice showed strong positive correlation (Pearson correlation coefficient = 0.66, p < 2.2 × 10−16) with GAB/CX3ert x APP/PS1 mice. In all panels the total App gene expression is labeled, which reports the sum of the mouse gene and human transgene expression in APP/PS1 carriers, to illustrate the effect of the transgenic construct.
Figure 5:
Figure 5:. Correlation analysis between mouse models and 30 human co-expression modules using the NanoString Mouse AD panel.
(A) Our mouse models showed a significant positive correlation (p < 0.05) with immune related modules STGblue and IFGturquoise in Consensus Cluster B. Circles within a square correspond to significant (p < 0.05) positive (blue) and negative (red) Pearson correlation coefficients. Color intensity and size of the circles are proportional to the correlation. (B) Common genes exhibiting directional coherence for gene expression changes between immune related STGblue module and all mouse models. (C) Common genes exhibiting directional coherence for gene expression changes between immune related IFGturquoise module and all mouse models.
Figure 6.
Figure 6.. Quantification of Aβ-40 and Aβ-42 in GAB/CX3ert x APP/PS1 mice compared to APP/PS1 mice.
(A) Significant increase in Aβ-40 and Aβ-42 was observed in male GAB/CX3ert mice compared to APP/PS1 mice. (B) No significant differences were observed in female GAB/CX3ert x APP/PS1 mice compared to female APP/PS1 mice. Data analysis through IBM SPSS Statistics v24. All data are shown as mean (±SEM); *p<.05.

References

    1. 2021 Alzheimer’s disease facts and figures. (2021). Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 17(3), 327–406. 10.1002/alz.12328 - DOI - PubMed
    1. Agalave NM, Lane BT, Mody PH, Szabo-Pardi TA, & Burton MD (2020). Isolation, culture, and downstream characterization of primary microglia and astrocytes from adult rodent brain and spinal cord. Journal of Neuroscience Methods, 340, 108742. 10.1016/j.jneumeth.2020.108742 - DOI - PMC - PubMed
    1. al-Dahan MI, & Thalmann RH (1996). Progesterone regulates gamma-aminobutyric acid B (GABAB) receptors in the neocortex of female rats. Brain Research, 727(1–2), 40–48. - PubMed
    1. Alam Q, Alam MZ, Mushtaq G, Damanhouri GA, Rasool M, Kamal MA, & Haque A (2016). Inflammatory Process in Alzheimer’s and Parkinson’s Diseases: Central Role of Cytokines. Current Pharmaceutical Design, 22(5), 541–548. - PubMed
    1. Álvarez-Aznar A, Martínez-Corral I, Daubel N, Betsholtz C, Mäkinen T, & Gaengel K (2020). Tamoxifen-independent recombination of reporter genes limits lineage tracing and mosaic analysis using CreERT2 lines. Transgenic Research, 29(1), 53–68. 10.1007/s11248-019-00177-8 - DOI - PMC - PubMed

Publication types

Substances